D’OXYVA is intended for significant enhancements in the regulation of the autonomic nervous system (ANS) including tissue microcirculation with cellular oxygenation, which is being recognized in a rapidly growing number of published randomized clinical trials leading to a variety of significant clinical outcomes. In short, D’OXYVA has demonstrated outsized improvements in blood circulation, cellular oxygenation, tissue perfusion in the microvessels, micro-, and macro-vascular functions, and neural signal activation in the autonomic nervous system according to randomized human clinical trials.
Microcirculation and autonomic nervous system dysfunction is increasingly regarded by the mainstream scientific medical community as the underlying cause of the most widespread health complications for both the young and elderly. Among other things, restrictions in these processes impede normal organ functions, the flow of antibodies, white blood cells and platelets, and rob the skin and body of oxygen and essential nutrients.
Blood flow (perfusion index), oxygen (SpO2 and TcPO2), blood pressure, blood glucose, heart rate variability, sympathetic/parasympathetic nerve activity, blood pH, and other vitals should be analyzed within 2 to 4 weeks after starting D’OXYVA and dosage adjusted according to results.
Stopping D’OXYVA after only 4 weeks is not recommended and it may not provide the expected long-term benefits even if major benefits and clinical outcomes were realized!
D’OXYVA is becoming exceptionally advantageous for the patient, health care practitioner, and the entire healthcare system, and is starting to provide substantial cost savings and improvements in quality of life for a wide variety of health complications for people of all ages and backgrounds.
Do not take D’OXYVA if you:
•are pregnant or think you may be pregnant, or are planning to become pregnant. D’OXYVA has never been reported or tested to cause harm to a pregnant woman or an unborn baby. U.S. FDA regulatory compliance requires that you are notified of any potential risks and if you get pregnant, stop taking D’OXYVA and call your doctor right away.
•are allergic to D’OXYVA or any of its ingredients. The active ingredient is purified carbon dioxide.
D’OXYVA has not been studied in children under 10 years of age.
•Store D’OXYVA at room temperature, 68 to 77°F (20 to 25°C).
•Do not keep medicine that is out of date or that you no longer need.
•Keep D’OXYVA and all medicines out of the reach of children. Be sure that if you throw medicine away, it is out of the reach of children.
Circularity Healthcare’s complaint handling is governed by ISO13485 Quality Management System and we usually replace items that malfunction due to manufacturing issues within 24-48 hours from approval of claim. Typically, approval takes about 24-72 hours from receipt of claim. Circularity’s D’OXYVA devices and EasyTwist Cartridges™ carry a 5-year limited warranty.
***We will refund your full D’OXYVA purchase price if you do not achieve any improvements (proof of purchase required, improvements measured from absolute baseline without taking D’OXYVA).
Please contact our customer service for more information about how to return your item. Thank you.
What You Need To Know!!!
Improves the rest and digestive function in the autonomic nervous system in the brain
IT HELPS IMPROVE
• Nutrient delivery
Chronic diabetes Vascular and burn Wounds
reported relief of persistent long-term chronic pain
D’OXYVA has been reviewed, studied, and used at prestigious institutions around the world.
Human Clinical Trial Results Show Outsized Circulation & Clinical Outcomes
D’OXYVA improved microcirculation (Skin Perfusion Pressure) in a statistically significant manner in 100% of subjects by about 15-100% from absolute baseline (median over 40%).
Improvement in blood flow peaked uniformly within 1 hour after a single 5-minute delivery on their thumb, and subsequently lasted for over 4 hours.
100% of enrolled subjects responded positively without adverse events after being monitored for a year after the study.
9 out of 10 users reported significant long-term health benefits after just 6-8 weeks of regular daily use